Lensar Inc Reports Results For The Quarter Ended March 31: Earnings Summary

LENSAR

08/05/2025 19:47

LENSAR Inc LNSR.OQ reported a quarterly adjusted loss of $2.32​​ per share for the quarter ended March 31, lower than the same quarter last year, when the company reported EPS of -19 cents.  The mean expectation of two analysts for the quarter was for a loss of 15 cents per share. Wall Street expected results to range from -17 cents to -14 cents per share.

Revenue rose 33.7% to $14.16 million from a year ago; analysts expected $13.40 million.

LENSAR Inc's reported EPS for the quarter was a loss of $2.32​.

The company reported a quarterly loss of $27.35 million.

LENSAR Inc shares had fallen by 2.1% this quarter and gained 54.7% so far this year.

FORECAST CHANGES

The mean earnings estimate of analysts had risen by about 31.1% in the last three months.​

In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

The current average analyst rating on the shares is "hold" and the breakdown of recommendations is no "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell." The average consensus recommendation for the advanced medical equipment & technology peer group is also "hold"

Wall Street's median 12-month price target for LENSAR Inc is $15.00

This summary was machine generated from LSEG data May 8 at 06:47 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDING
ESTIMATE
ACTUAL
BEAT, MET, MISSED
Mar. 31 2025
-0.15
-2.32
Missed
Dec. 31 2024
-0.18
-1.61
Missed
Sep. 30 2024
-0.29
-0.13
Beat
Jun. 30 2024
-0.29
-0.79
Missed